Furthermore, the ERK pathway inhibition by the ERK1/2 inhibitor could also impede XPC deficiency-induced cell proliferation (Figures 5E-F). This evidence concerns the gene MAPK3 and hyperinsulinemic hypoglycemia, familial, 4.